STOCK TITAN

[8-K] Precigen, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Travelzoo (TZOO) Form 4 filing dated 06/30/2025 discloses insider selling by 10% owner Azzurro Capital Inc., an entity controlled by director Ralph Bartel. On 06/27/2025 the insider sold 76,500 common shares at prices ranging from $13.00-$13.41 (volume-weighted average reported as $13.15). Following the sale, Azzurro Capital still beneficially owns 4,062,696 shares. Ralph Bartel and the Ralph Bartel 2005 Trust report indirect ownership of the same block.

The transaction represents roughly 1.9 % of the insider’s reported holdings, leaving the group well above the 10 % ownership threshold. No derivative securities were involved and no other transactions were reported for the period. The filing does not reference a pre-arranged 10b5-1 plan, implying discretionary execution.

For investors, director-level selling can raise questions about short-term sentiment, although the modest size relative to the remaining stake may limit market impact. The insider maintains a substantial position, suggesting continued long-term alignment with shareholders.

Il modulo Form 4 di Travelzoo (TZOO) datato 30/06/2025 rivela una vendita da parte di un insider, Azzurro Capital Inc., che detiene il 10% della società ed è controllata dal direttore Ralph Bartel. Il 27/06/2025 l'insider ha venduto 76.500 azioni ordinarie a prezzi compresi tra $13,00 e $13,41 (media ponderata per volume riportata a $13,15). Dopo la vendita, Azzurro Capital possiede ancora 4.062.696 azioni in modo beneficiario. Ralph Bartel e il Ralph Bartel 2005 Trust dichiarano la proprietà indiretta dello stesso blocco.

La transazione rappresenta circa il 1,9% delle partecipazioni dichiarate dall’insider, mantenendo il gruppo ben al di sopra della soglia del 10%. Non sono stati coinvolti strumenti derivati e non sono state segnalate altre transazioni nel periodo. Il modulo non fa riferimento a un piano predefinito 10b5-1, suggerendo un’esecuzione discrezionale.

Per gli investitori, la vendita da parte di un membro del consiglio può sollevare dubbi sul sentiment a breve termine, anche se la dimensione modesta rispetto alla partecipazione residua potrebbe limitare l’impatto sul mercato. L’insider mantiene una posizione significativa, indicando un allineamento continuativo a lungo termine con gli azionisti.

El formulario Form 4 de Travelzoo (TZOO) fechado el 30/06/2025 revela una venta interna por parte de Azzurro Capital Inc., propietario del 10% y entidad controlada por el director Ralph Bartel. El 27/06/2025, el insider vendió 76,500 acciones ordinarias a precios entre $13.00 y $13.41 (promedio ponderado por volumen reportado en $13.15). Tras la venta, Azzurro Capital aún posee beneficiosamente 4,062,696 acciones. Ralph Bartel y el Ralph Bartel 2005 Trust informan propiedad indirecta del mismo bloque.

La transacción representa aproximadamente el 1.9% de las participaciones reportadas por el insider, manteniendo al grupo muy por encima del umbral del 10%. No hubo valores derivados involucrados ni otras transacciones reportadas en el periodo. El formulario no menciona un plan 10b5-1 preestablecido, lo que implica una ejecución discrecional.

Para los inversores, la venta a nivel directivo puede generar dudas sobre el sentimiento a corto plazo, aunque el tamaño modesto en relación con la participación restante podría limitar el impacto en el mercado. El insider mantiene una posición sustancial, lo que sugiere una alineación continua a largo plazo con los accionistas.

Travelzoo (TZOO)의 2025년 6월 30일자 Form 4 제출서류에 따르면, 이사 Ralph Bartel이 통제하는 10% 소유주 Azzurro Capital Inc.가 내부자 주식 매각을 공시했습니다. 2025년 6월 27일, 내부자는 76,500주 보통주를 주당 $13.00~$13.41 가격으로 매도했으며(거래량 가중 평균 가격은 $13.15로 보고됨), 매도 후 Azzurro Capital은 여전히 4,062,696주를 실질적으로 보유하고 있습니다. Ralph Bartel과 Ralph Bartel 2005 Trust도 동일한 주식 블록에 대한 간접 소유를 보고했습니다.

이번 거래는 내부자가 보고한 보유 지분의 약 1.9%에 해당하며, 그룹은 여전히 10% 소유 기준선을 훨씬 상회하고 있습니다. 파생상품 증권은 포함되지 않았으며, 해당 기간 내 다른 거래도 보고되지 않았습니다. 제출서류에는 사전 설정된 10b5-1 계획이 언급되어 있지 않아 재량에 따른 실행임을 시사합니다.

투자자 입장에서는 이사급 내부자의 매도가 단기적인 심리 변화를 암시할 수 있으나, 남은 지분에 비해 규모가 작아 시장에 미치는 영향은 제한적일 수 있습니다. 내부자는 상당한 지분을 유지하고 있어 장기적으로 주주와의 이해관계가 지속됨을 나타냅니다.

Le dépôt du formulaire Form 4 de Travelzoo (TZOO) daté du 30/06/2025 révèle une vente d’initié par Azzurro Capital Inc., propriétaire de 10 % et entité contrôlée par le directeur Ralph Bartel. Le 27/06/2025, l’initié a vendu 76 500 actions ordinaires à des prix allant de (moyenne pondérée par volume rapportée à 13,15 $). Après la vente, Azzurro Capital détient toujours 4 062 696 actions bénéficiaires. Ralph Bartel et le Ralph Bartel 2005 Trust déclarent une propriété indirecte du même bloc.

La transaction représente environ 1,9 % des participations déclarées de l’initié, laissant le groupe bien au-dessus du seuil de 10 %. Aucun titre dérivé n’a été impliqué et aucune autre transaction n’a été signalée pour la période. Le dépôt ne fait pas référence à un plan 10b5-1 préétabli, ce qui implique une exécution discrétionnaire.

Pour les investisseurs, une vente au niveau des administrateurs peut susciter des interrogations sur le sentiment à court terme, bien que la taille modeste par rapport à la participation restante puisse limiter l’impact sur le marché. L’initié conserve une position substantielle, suggérant un alignement à long terme avec les actionnaires.

Die Form 4-Meldung von Travelzoo (TZOO) vom 30.06.2025 offenbart Insider-Verkäufe durch den 10%-Eigentümer Azzurro Capital Inc., eine von Direktor Ralph Bartel kontrollierte Einheit. Am 27.06.2025 verkaufte der Insider 76.500 Stammaktien zu Preisen zwischen (volumengewichteter Durchschnittspreis von $13,15). Nach dem Verkauf besitzt Azzurro Capital weiterhin 4.062.696 Aktien wirtschaftlich. Ralph Bartel und der Ralph Bartel 2005 Trust melden indirekten Besitz des gleichen Blocks.

Die Transaktion entspricht etwa 1,9 % der gemeldeten Insider-Beteiligung und lässt die Gruppe deutlich über der 10%-Besitzschwelle. Es waren keine Derivate beteiligt, und für den Zeitraum wurden keine weiteren Transaktionen gemeldet. Die Meldung verweist nicht auf einen vorab vereinbarten 10b5-1-Plan, was auf eine diskretionäre Ausführung hindeutet.

Für Investoren können Verkäufe auf Direktorenebene Fragen zum kurzfristigen Sentiment aufwerfen, obwohl die geringe Größe im Verhältnis zum verbleibenden Anteil die Marktwirkung begrenzen dürfte. Der Insider hält weiterhin eine bedeutende Position, was auf eine langfristige Ausrichtung mit den Aktionären schließen lässt.

Positive
  • Insider retains 4,062,696 shares, preserving significant alignment with shareholders.
Negative
  • Director and 10 % owner sold 76,500 shares (~1.9 % of holdings), potentially signaling reduced short-term confidence.

Insights

TL;DR: Director-level insider sold 1.9 % of stake; modest but signals slight negative sentiment.

The 76,500-share sale at ~$13.15 yields proceeds of about $1.0 million. While any open-market sale by a 10 % owner is worth noting, the percentage of holdings disposed (<2 %) is small, and the filer retains over 4 million shares. The absence of derivative activity and lack of a stated 10b5-1 plan indicates active portfolio management rather than automatic liquidation. Given the limited size, I classify the event as incrementally negative but not materially impactful to Travelzoo’s fundamental outlook.

TL;DR: Transaction is routine; ownership still strong, overall impact neutral.

Ralph Bartel remains Travelzoo’s largest shareholder and continues to serve as director. The filing complies with Section 16 timing requirements and provides price transparency. Because the insider retains a dominant ownership position, governance control dynamics are unchanged. I view the trade as non-material from a governance perspective; thus, it is essentially neutral for long-term investors.

Il modulo Form 4 di Travelzoo (TZOO) datato 30/06/2025 rivela una vendita da parte di un insider, Azzurro Capital Inc., che detiene il 10% della società ed è controllata dal direttore Ralph Bartel. Il 27/06/2025 l'insider ha venduto 76.500 azioni ordinarie a prezzi compresi tra $13,00 e $13,41 (media ponderata per volume riportata a $13,15). Dopo la vendita, Azzurro Capital possiede ancora 4.062.696 azioni in modo beneficiario. Ralph Bartel e il Ralph Bartel 2005 Trust dichiarano la proprietà indiretta dello stesso blocco.

La transazione rappresenta circa il 1,9% delle partecipazioni dichiarate dall’insider, mantenendo il gruppo ben al di sopra della soglia del 10%. Non sono stati coinvolti strumenti derivati e non sono state segnalate altre transazioni nel periodo. Il modulo non fa riferimento a un piano predefinito 10b5-1, suggerendo un’esecuzione discrezionale.

Per gli investitori, la vendita da parte di un membro del consiglio può sollevare dubbi sul sentiment a breve termine, anche se la dimensione modesta rispetto alla partecipazione residua potrebbe limitare l’impatto sul mercato. L’insider mantiene una posizione significativa, indicando un allineamento continuativo a lungo termine con gli azionisti.

El formulario Form 4 de Travelzoo (TZOO) fechado el 30/06/2025 revela una venta interna por parte de Azzurro Capital Inc., propietario del 10% y entidad controlada por el director Ralph Bartel. El 27/06/2025, el insider vendió 76,500 acciones ordinarias a precios entre $13.00 y $13.41 (promedio ponderado por volumen reportado en $13.15). Tras la venta, Azzurro Capital aún posee beneficiosamente 4,062,696 acciones. Ralph Bartel y el Ralph Bartel 2005 Trust informan propiedad indirecta del mismo bloque.

La transacción representa aproximadamente el 1.9% de las participaciones reportadas por el insider, manteniendo al grupo muy por encima del umbral del 10%. No hubo valores derivados involucrados ni otras transacciones reportadas en el periodo. El formulario no menciona un plan 10b5-1 preestablecido, lo que implica una ejecución discrecional.

Para los inversores, la venta a nivel directivo puede generar dudas sobre el sentimiento a corto plazo, aunque el tamaño modesto en relación con la participación restante podría limitar el impacto en el mercado. El insider mantiene una posición sustancial, lo que sugiere una alineación continua a largo plazo con los accionistas.

Travelzoo (TZOO)의 2025년 6월 30일자 Form 4 제출서류에 따르면, 이사 Ralph Bartel이 통제하는 10% 소유주 Azzurro Capital Inc.가 내부자 주식 매각을 공시했습니다. 2025년 6월 27일, 내부자는 76,500주 보통주를 주당 $13.00~$13.41 가격으로 매도했으며(거래량 가중 평균 가격은 $13.15로 보고됨), 매도 후 Azzurro Capital은 여전히 4,062,696주를 실질적으로 보유하고 있습니다. Ralph Bartel과 Ralph Bartel 2005 Trust도 동일한 주식 블록에 대한 간접 소유를 보고했습니다.

이번 거래는 내부자가 보고한 보유 지분의 약 1.9%에 해당하며, 그룹은 여전히 10% 소유 기준선을 훨씬 상회하고 있습니다. 파생상품 증권은 포함되지 않았으며, 해당 기간 내 다른 거래도 보고되지 않았습니다. 제출서류에는 사전 설정된 10b5-1 계획이 언급되어 있지 않아 재량에 따른 실행임을 시사합니다.

투자자 입장에서는 이사급 내부자의 매도가 단기적인 심리 변화를 암시할 수 있으나, 남은 지분에 비해 규모가 작아 시장에 미치는 영향은 제한적일 수 있습니다. 내부자는 상당한 지분을 유지하고 있어 장기적으로 주주와의 이해관계가 지속됨을 나타냅니다.

Le dépôt du formulaire Form 4 de Travelzoo (TZOO) daté du 30/06/2025 révèle une vente d’initié par Azzurro Capital Inc., propriétaire de 10 % et entité contrôlée par le directeur Ralph Bartel. Le 27/06/2025, l’initié a vendu 76 500 actions ordinaires à des prix allant de (moyenne pondérée par volume rapportée à 13,15 $). Après la vente, Azzurro Capital détient toujours 4 062 696 actions bénéficiaires. Ralph Bartel et le Ralph Bartel 2005 Trust déclarent une propriété indirecte du même bloc.

La transaction représente environ 1,9 % des participations déclarées de l’initié, laissant le groupe bien au-dessus du seuil de 10 %. Aucun titre dérivé n’a été impliqué et aucune autre transaction n’a été signalée pour la période. Le dépôt ne fait pas référence à un plan 10b5-1 préétabli, ce qui implique une exécution discrétionnaire.

Pour les investisseurs, une vente au niveau des administrateurs peut susciter des interrogations sur le sentiment à court terme, bien que la taille modeste par rapport à la participation restante puisse limiter l’impact sur le marché. L’initié conserve une position substantielle, suggérant un alignement à long terme avec les actionnaires.

Die Form 4-Meldung von Travelzoo (TZOO) vom 30.06.2025 offenbart Insider-Verkäufe durch den 10%-Eigentümer Azzurro Capital Inc., eine von Direktor Ralph Bartel kontrollierte Einheit. Am 27.06.2025 verkaufte der Insider 76.500 Stammaktien zu Preisen zwischen (volumengewichteter Durchschnittspreis von $13,15). Nach dem Verkauf besitzt Azzurro Capital weiterhin 4.062.696 Aktien wirtschaftlich. Ralph Bartel und der Ralph Bartel 2005 Trust melden indirekten Besitz des gleichen Blocks.

Die Transaktion entspricht etwa 1,9 % der gemeldeten Insider-Beteiligung und lässt die Gruppe deutlich über der 10%-Besitzschwelle. Es waren keine Derivate beteiligt, und für den Zeitraum wurden keine weiteren Transaktionen gemeldet. Die Meldung verweist nicht auf einen vorab vereinbarten 10b5-1-Plan, was auf eine diskretionäre Ausführung hindeutet.

Für Investoren können Verkäufe auf Direktorenebene Fragen zum kurzfristigen Sentiment aufwerfen, obwohl die geringe Größe im Verhältnis zum verbleibenden Anteil die Marktwirkung begrenzen dürfte. Der Insider hält weiterhin eine bedeutende Position, was auf eine langfristige Ausrichtung mit den Aktionären schließen lässt.

false 0001356090 0001356090 2025-06-26 2025-06-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 26, 2025

 

Precigen, Inc.

(Exact name of registrant as specified in its charter)

 

Virginia   001-36042   26-0084895

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

20374 Seneca Meadows Parkway, Germantown, Maryland 20876

(Address of principal executive offices) (Zip Code)

 

(301) 556-9900

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, No Par Value   PGEN   Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

 

 

 

Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

At the Annual Meeting of Stockholders of Precigen, Inc. (the “Company”) held on June 26, 2025 (the “2025 Annual Meeting”), the Company’s stockholders approved an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as amended (the “2023 Plan”), to increase the number of shares of common stock available for issuance thereunder by 11.5 million (the “2023 Plan Amendment No. 2”). The approval of the 2023 Plan Amendment No. 2 had been previously approved by the Company’s Board of Directors (the “Board”), subject to stockholder approval.

 

The 2023 Plan Amendment No. 2 amends the 2023 Plan, which was previously approved by the Company’s stockholders on June 8, 2023, and subsequently amended by the Company’s stockholders on July 5, 2024. The principal features of the 2023 Plan Amendment No. 2 are described in detail under “Proposal 6 - Approval of an Amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as Amended (the “2023 Plan”)” of the Company’s Definitive Proxy Statement on Schedule 14A for the 2025 Annual Meeting filed by the Company with the Securities and Exchange Commission on May 16, 2025 (the “Proxy Statement”). The full text of the 2023 Plan Amendment No. 2 is attached as Annex A to the Proxy Statement.

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

At the 2025 Annual Meeting, the Company’s stockholders (i) elected each of the persons listed below as a director for a one-year term, (ii) approved an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the Company’s authorized shares of common stock thereunder by 300 million, (iii) approved, in compliance with Nasdaq Listing Rule 5635(c), of the issuance of the Company’s shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends on the Series A Preferred Stock, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors, (iv) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, (v) approved a non-binding advisory resolution approving the compensation of the named executive officers, (vi) approved the 2023 Plan Amendment No. 2, and (vii) approved an amendment to the Precigen, Inc. 2019 Incentive Plan for Non-Employee Service Providers to increase the number of shares of common stock which may be subject to awards thereunder by 1.1 million.

 

Proposal 1 - Election of directors.

 

  For   Against   Abstain   Broker Non-Votes
Randal Kirk 174,246,854   4,768,225   1,016,706   49,304,662
Nancy Howell Agee 173,396,985   5,390,070   1,244,730   49,304,662
Cesar Alvarez 160,583,877   19,128,648   319,260   49,304,662
Steven Frank 173,794,818   5,102,748   1,134,219   49,304,662
Vinita Gupta 174,703,376   4,982,011   346,398   49,304,662
Fred Hassan 174,576,158   5,131,655   323,972   49,304,662
Jeffrey Kindler 175,464,120   4,250,540   317,125   49,304,662
Helen Sabzevari 177,883,914   1,926,042   221,829   49,304,662
James Turley 174,538,663   5,171,322   321,800   49,304,662

 

Proposal 2 - Approval of an amendment to the Company’s Amended and Restated Articles of Incorporation to increase authorized shares of common stock thereunder by 300 million.

 

For Against Abstain
223,238,979 5,603,517 493,951

 

Proposal 3 - Approval, in compliance with Nasdaq Listing Rule 5625(c), of the issuance of the Company’s shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends on the Series A Preferred Stock, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors.

 

For Against Abstain Broker Non-Votes
167,387,561 11,685,114 959,110 49,304,662

 

 

 

Proposal 4 - Ratification of the Appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

 

For Against Abstain
228,912,465 373,134 50,848

 

Proposal 5 - Non-binding advisory resolution approving the compensation of the named executive officers.

 

For Against Abstain Broker Non-Votes
175,928,061 3,683,746 419,978 49,304,662

 

Proposal 6 - Approval of an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as amended, to increase the number of shares of common stock which may be subject to awards thereunder by 11.5 million.

 

For Against Abstain Broker Non-Votes
177,057,566 2,697,429 276,790 49,304,662

 

Proposal 7 - Approval of an amendment to the Precigen, Inc. 2019 Incentive Plan for Non-Employee Service Providers, as amended, to increase the number of shares of common stock which may be subject to awards thereunder by 1.1 million.

 

For Against Abstain Broker Non-Votes
174,026,158 5,734,546 271,081 49,304,662

 

Item 9.01.Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

No.

  Description
     
104   Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Precigen, Inc.
   
     
  By:

/s/ Donald P. Lehr

    Donald P. Lehr
    Chief Legal Officer

 

Dated: June 30, 2025

 

 

 

 

FAQ

How many Travelzoo (TZOO) shares did Azzurro Capital sell?

The filing reports a sale of 76,500 common shares.

What price range were the TZOO shares sold at?

Shares were sold between $13.00 and $13.41, with an average listed at $13.15.

How many TZOO shares does the insider still own after the sale?

Azzurro Capital remains beneficial owner of 4,062,696 shares.

Does the sale affect the insider’s 10 % ownership status?

No. Even after the sale, the insider’s stake exceeds the 10 % threshold.

Was this sale executed under a Rule 10b5-1 trading plan?

The Form 4 does not indicate that the transaction was made pursuant to a 10b5-1 plan.
Precigen Inc

NASDAQ:PGEN

PGEN Rankings

PGEN Latest News

PGEN Latest SEC Filings

PGEN Stock Data

419.16M
264.14M
10.01%
66.34%
7.37%
Biotechnology
Pharmaceutical Preparations
Link
United States
GERMANTOWN